{"id":"W2149953725","doi":"10.1093/annonc/mdt069","title":"Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; Capital District Health Authority","funders":"Breast Cancer Society of Canada; Beatrice Hunter Cancer Research Institute","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Internal medicine; Adjuvant; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004799298,0.0002275339,0.0008075039,0.0001666328,0.00007753688,0.00001299715,0.0002100863,0.0002589433,0.001584481],"category_scores_gemma":[0.000100669,0.0001839842,0.0003006939,0.0002547591,0.0003253087,0.0001092236,0.00005238428,0.0003372686,0.0001082989],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003701688,"about_ca_system_score_gemma":0.001166813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002611666,"about_ca_topic_score_gemma":0.0001441796,"domain_scores_codex":[0.9979559,0.000203252,0.0003825215,0.0004438768,0.0003358655,0.0006786014],"domain_scores_gemma":[0.9971198,0.0006928545,0.0001787686,0.0003341815,0.001385842,0.0002885821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002408375,0.0008217493,0.004102372,0.0001192977,0.0005521319,0.00002403781,0.001661232,0.00000581329,0.01095334,0.00005948241,0.09447311,0.8848191],"study_design_scores_gemma":[0.0145896,0.03551397,0.4185227,0.0005387681,0.0001493844,0.0003091059,0.001128468,0.0008319172,0.1352272,0.001176217,0.3914833,0.0005293224],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8421176,0.004143728,0.0002296817,0.1296163,0.000463446,0.01479422,0.0009889562,0.00006814959,0.007577895],"genre_scores_gemma":[0.9769383,0.002931192,0.00019035,0.01091248,0.000456251,0.0076277,0.00002601809,0.00005745567,0.0008602453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8842897,"threshold_uncertainty_score":0.9993282,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1411204572597438,"score_gpt":0.4968204685723518,"score_spread":0.355700011312608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}